BHV-1400 Clinical Trials (2026): 2 Studies for IgA Nephropathy
Hipa.ai Research · Source: ClinicalTrials.gov / AACT
Synced daily from ClinicalTrials.gov via AACT. Last sync: .
2 BHV-1400 clinical trials are catalogued on Hipa.ai from the AACT mirror of ClinicalTrials.gov, spanning 1 indication (including IgA Nephropathy) and 440 total planned enrollment. 1 Phase 3 BHV-1400 trial are listed. 2 BHV-1400 clinical trials are actively recruiting at 14 U.S. sites across 10 states. Most recent activity: NCT07642050 (Oct 2029).
Where to Participate: All BHV-1400 Trial Sites in the U.S. (14 sites across 10 states)
Every actively recruiting BHV-1400trial site, sorted by state then city. Each row links to the trial detail page (eligibility, contacts, full study record). Sites no longer enrolling at the location level are excluded. ClinicalTrials.gov / AACT does not provide street-level addresses; the map link uses the facility's geocoded coordinates where available.
| State | Facility | City | Trial | Map |
|---|---|---|---|---|
| CT | Site-001 | Farmington06030 | NCT07054684 | Map |
| FL | Site-003 | Miami Lakes33016 | NCT07054684 | Map |
| FL | Site-011 | Miami Lakes33172 | NCT07054684 | Map |
| FL | Site-013 | Orlando32806 | NCT07054684 | Map |
| FL | Site-005 | Pembroke Pines33029 | NCT07054684 | Map |
| GA | Site-008 | Lawrenceville30046 | NCT07054684 | Map |
| IL | Site-009 | Hinsdale60521 | NCT07054684 | Map |
| IN | Site-012 | Indianapolis46268 | NCT07054684 | Map |
| MI | Site-015 | Shelby48316 | NCT07054684 | Map |
| MO | Site-006 | Chesterfield63017 | NCT07054684 | Map |
| SD | Site-002 | Dakota Dunes57049 | NCT07054684 | Map |
| TX | Site-004 | Houston77099 | NCT07054684 | Map |
| TX | Site-014 | Houston77027 | NCT07054684 | Map |
| UT | Site-016 | Salt Lake City84115 | NCT07054684 | Map |
BHV-1400 clinical trials at a glance: phase × recruitment status
| Phase | recruiting | not yet recruiting | Total |
|---|---|---|---|
| P1 | 1 | 1 | |
| P3 | 1 | 1 |
Recruiting BHV-1400 clinical trials (2)
Studies currently enrolling participants. Click any NCT ID to view the trial detail page (eligibility, sites, contacts).
| NCT ID | Title | Phase | Indication | Enrollment | Started |
|---|---|---|---|---|---|
| NCT07642050 | A Study to Determine if BHV-1400 is Effective and Safe in Adults With IgA Nephropathy | P3 | IgA Nephropathy | 420 | Jun 2026 |
| NCT07054684 | Study of BHV-1400 in IgA Nephropathy | P1 | IgA Nephropathy | 20 | Jul 2025 |
All BHV-1400 trials (2)
Sorted by most recent activity (completion → start → posted date). Each row links to the trial detail page on Hipa.ai.
| NCT ID | Acronym | Title | Phase | Status | Enrollment | Sponsor | Started |
|---|---|---|---|---|---|---|---|
| NCT07642050 | A Study to Determine if BHV-1400 is Effective and Safe in Adults With IgA Nephropathy | P3 | not yet recruiting | 420 | Biohaven Therapeutics Ltd. | Jun 2026 | |
| NCT07054684 | Study of BHV-1400 in IgA Nephropathy | P1 | recruiting | 20 | Biohaven Therapeutics Ltd. | Jul 2025 |
BHV-1400 clinical trials: frequently asked questions
- How many BHV-1400 clinical trials are there?
- 2 BHV-1400 clinical trials are catalogued on Hipa.ai, sourced from the AACT mirror of ClinicalTrials.gov. 1 is actively recruiting participants.
- Are BHV-1400 clinical trials recruiting in 2026?
- Yes — 1 BHV-1400 trial is actively recruiting in 2026, with 14 U.S. sites across 10 states. See the recruiting trials and the per-state site list further down this page.
- What conditions is BHV-1400 being studied for?
- BHV-1400 is being studied for IgA Nephropathy. The trials are grouped by indication on this page.
- What phase is BHV-1400 in?
- BHV-1400 clinical trials span 1 Phase 3, 1 Phase 1. The phase × status matrix at the top of this page breaks down counts by phase and recruitment status.
- Who sponsors BHV-1400 clinical trials?
- The lead sponsor across the most BHV-1400 trials is Biohaven Therapeutics Ltd.. Each trial row links to the full study detail page including sponsor information.
Sources and methodology
Trial inventory derived from the AACT mirror of ClinicalTrials.gov. Trials are filtered to those naming BHV-1400as an intervention. Phase, status, enrollment, sponsor, and dates are taken from the source `studies` table; primary indication is the first listed condition. Acronyms are extracted from each trial's brief title where present. PubMed links are populated for trials whose published primary outcomes have been indexed in our evidence cache.
Last refreshed .
Related pages on Hipa.ai: